US 11786554
Optimized engineered nucleases having specificity for the human T cell receptor alpha constant region gene
granted A61KA61K2239/48A61K35/76
Quick answer
US patent 11786554 (Optimized engineered nucleases having specificity for the human T cell receptor alpha constant region gene) held by Precision BioSciences, Inc. expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Precision BioSciences, Inc.
- Grant date
- Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K2239/48, A61K35/76, A61K40/11, A61K40/31